European Companies Search Engine
Managing Director (2) · Change of headquarters: Neuraxo-Biotec GmbH · Capital: €280,650 · Shareholder agreement · Proxy policy · Corporate Purpose Hrb9 Mar 2006 German Trade Register Announcements, Germany (08/03/2006)
Overview
Text
Neuraxo Biopharmaceuticals GmbH, Erkrath (
Unnamed street ??, 40699 Erkrath, Germany
). GmbH. Partnership agreement of May 15, 2001, amended several times. The shareholders' meeting of November 10, 2005 decided to transfer the registered office from Düsseldorf (previously Amtsgericht Düsseldorf HRB 40973) to Erkrath and with it the amendment of the partnership agreement in Section 1 (company and registered office) and Section 7 (3) sentence 1 (liquidation proceeds). Subject: Research, development, testing, financing and marketing of procedures for the regeneration of spinal cord and/or brain damage caused by illness or accident, research and development of active substances and combinations of active substances for procedures for the regeneration of spinal cord and/or brain damage caused by illness or accident, advice and training of medical personnel in the application and marketing of procedures for the treatment of disease or accidental spinal cord damage. Share capital: EUR 280,650.00. General representation scheme: If only one managing director is appointed, he shall represent the company alone. If several directors are appointed, the company is represented by two directors or by a managing director together with an authorized representative. Managing Director: Dr. ?????????????, ??????, Darmstadt, *??.??.????, authorized to enter into legal transactions on behalf of the company with the power to represent himself or as a representative of a third party. Managing Director: Dr. ?????, ????? ??, Grafing, *??.??.???? to enter into legal transactions on behalf of the company in its own name or a.s. a representative of a third party.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: SCT Spinal Cord Therapeutics GmbH, Erkrath, Germany.